ImClone deal hurt Lilly’s fourth quarter-WEB ONLY
Eli Lilly and Co. posted a $3.6 billion fourth-quarter loss because of its $6.5 billion acquisition of New York-based ImClone Systems Inc. Not counting that deal, however, Lilly’s profits beat the expectations of Wall Street analysts by two cents per share. Indianapolis-based Lilly earned $1.07 per share excluding the ImClone purchase. Analysts were expecting $1.05 […]